These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 38299825)
1. Resistance, mechanism, and fitness cost of specific bacteriophages for Feng L; Chen H; Qian C; Zhao Y; Wang W; Liu Y; Xu M; Cao J; Zhou T; Wu Q mSphere; 2024 Feb; 9(2):e0055323. PubMed ID: 38299825 [TBL] [Abstract][Full Text] [Related]
2. Study of Combined Effect of Bacteriophage vB3530 and Chlorhexidine on the Inactivation of Pseudomonas aeruginosa. Liu Y; Zhao Y; Qian C; Huang Z; Feng L; Chen L; Yao Z; Xu C; Ye J; Zhou T BMC Microbiol; 2023 Sep; 23(1):256. PubMed ID: 37704976 [TBL] [Abstract][Full Text] [Related]
3. Fluctuating Bacteriophage-induced galU Deficiency Region is Involved in Trade-off Effects on the Phage and Fluoroquinolone Sensitivity in Pseudomonas aeruginosa. Nakamura K; Fujiki J; Nakamura T; Furusawa T; Gondaira S; Usui M; Higuchi H; Tamura Y; Iwano H Virus Res; 2021 Dec; 306():198596. PubMed ID: 34648885 [TBL] [Abstract][Full Text] [Related]
4. A Novel N4-Like Bacteriophage Isolated from a Wastewater Source in South India with Activity against Several Multidrug-Resistant Clinical Pseudomonas aeruginosa Isolates. Menon ND; Kumar MS; Satheesh Babu TG; Bose S; Vijayakumar G; Baswe M; Chatterjee M; D'Silva JR; Shetty K; Haripriyan J; Kumar A; Nair S; Somanath P; Nair BG; Nizet V; Kumar GB mSphere; 2021 Jan; 6(1):. PubMed ID: 33441405 [TBL] [Abstract][Full Text] [Related]
5. Antibiofilm potential of purified environmental bacteriophage preparations against early stage Pseudomonas aeruginosa biofilms. Issa R; Chanishvili N; Caplin J; Kakabadze E; Bakuradze N; Makalatia K; Cooper I J Appl Microbiol; 2019 Jun; 126(6):1657-1667. PubMed ID: 30825355 [TBL] [Abstract][Full Text] [Related]
6. The uncharacterized PA3040-3042 operon is part of the cell envelope stress response and a tobramycin resistance determinant in a clinical isolate of Østergaard MZ; Nielsen FD; Meinfeldt MH; Kirkpatrick CL Microbiol Spectr; 2024 Aug; 12(8):e0387523. PubMed ID: 38949386 [TBL] [Abstract][Full Text] [Related]
9. Bacteriophage PEV20 and Ciprofloxacin Combination Treatment Enhances Removal of Pseudomonas aeruginosa Biofilm Isolated from Cystic Fibrosis and Wound Patients. Chang RYK; Das T; Manos J; Kutter E; Morales S; Chan HK AAPS J; 2019 Apr; 21(3):49. PubMed ID: 30949776 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a new Whiteley LE; Whiteley M Microbiol Spectr; 2024 Mar; 12(3):e0371923. PubMed ID: 38345389 [TBL] [Abstract][Full Text] [Related]
11. Engineered Bacteriophages Containing Anti-CRISPR Suppress Infection of Antibiotic-Resistant P. aeruginosa. Qin S; Liu Y; Chen Y; Hu J; Xiao W; Tang X; Li G; Lin P; Pu Q; Wu Q; Zhou C; Wang B; Gao P; Wang Z; Yan A; Nadeem K; Xia Z; Wu M Microbiol Spectr; 2022 Oct; 10(5):e0160222. PubMed ID: 35972246 [TBL] [Abstract][Full Text] [Related]
12. Activity of Bacteriophages in Removing Biofilms of Fong SA; Drilling A; Morales S; Cornet ME; Woodworth BA; Fokkens WJ; Psaltis AJ; Vreugde S; Wormald PJ Front Cell Infect Microbiol; 2017; 7():418. PubMed ID: 29018773 [No Abstract] [Full Text] [Related]
13. Quorum Sensing Promotes Phage Infection in Pseudomonas aeruginosa PAO1. Xuan G; Lin H; Tan L; Zhao G; Wang J mBio; 2022 Feb; 13(1):e0317421. PubMed ID: 35038901 [TBL] [Abstract][Full Text] [Related]
14. Isolation and Characterization of Three Pseudomonas aeruginosa Viruses with Therapeutic Potential. Wang X; Tang J; Dang W; Xie Z; Zhang F; Hao X; Sun S; Liu X; Luo Y; Li M; Gu Y; Wang Y; Chen Q; Shen X; Xu L Microbiol Spectr; 2023 Jun; 11(3):e0463622. PubMed ID: 37125933 [TBL] [Abstract][Full Text] [Related]
15. [Biological characteristics and genomic information of a bacteriophage against pan-drug resistant Qi ZY; Yang SY; Dong SW; Zhao FF; Qin JH; Xiang J Zhonghua Shao Shang Za Zhi; 2020 Jan; 36(1):14-23. PubMed ID: 32023713 [No Abstract] [Full Text] [Related]
16. Identification and impact on Forti F; Bertoli C; Cafora M; Gilardi S; Pistocchi A; Briani F Microbiol Spectr; 2023 Dec; 11(6):e0147723. PubMed ID: 37966242 [TBL] [Abstract][Full Text] [Related]
17. Enhancement of bactericidal effects of bacteriophage and gentamicin combination regimen against Staphylococcus aureus and Pseudomonas aeruginosa strains in a mice diabetic wound model. Jokar J; Abdulabbas HT; Javanmardi K; Mobasher MA; Jafari S; Ghasemian A; Rahimian N; Zarenezhad A; ُSoltani Hekmat A Virus Genes; 2024 Feb; 60(1):80-96. PubMed ID: 38079060 [TBL] [Abstract][Full Text] [Related]
18. Bacteriophage can lyse antibiotic-resistant Pseudomonas aeruginosa isolated from canine diseases. Furusawa T; Iwano H; Higuchi H; Yokota H; Usui M; Iwasaki T; Tamura Y J Vet Med Sci; 2016 Jul; 78(6):1035-8. PubMed ID: 26876365 [TBL] [Abstract][Full Text] [Related]
19. Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing. Holger DJ; Lev KL; Kebriaei R; Morrisette T; Shah R; Alexander J; Lehman SM; Rybak MJ J Appl Microbiol; 2022 Sep; 133(3):1636-1649. PubMed ID: 35652690 [TBL] [Abstract][Full Text] [Related]
20. Bacteriophage therapy in implant-related infections: an experimental study. Yilmaz C; Colak M; Yilmaz BC; Ersoz G; Kutateladze M; Gozlugol M J Bone Joint Surg Am; 2013 Jan; 95(2):117-25. PubMed ID: 23324958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]